This application is a National Stage Application of International Application No. PCT/AU2008/001718, filed Nov. 19, 2008, entitled “ELECTRODE ARRAY FOR A COCHLEAR IMPLANT,” which claims priority from Australian Provisional Patent Application No. 2007906334, filed Nov. 19, 2007. The contents of these applications are hereby incorporated by reference herein.
1. Field of the Invention
This invention relates to implants having electrodes and/or contacts for conducting electrical signals and/or delivering energy directly to one or more parts of a patient's body.
2. Related Art
The following publications are referred to in the present application and their contents are hereby incorporated by reference in their entirety: “Multifunctional Carbon Nanotube Yarns by Downsizing an Ancient Technology”, Science Vol. 306. no. 5700, pp. 1358-1361; “Strong, Transparent, Multifunctional, Carbon Nanotube Sheets”, Science Vol. 309. no. 5738, pp. 1215-1219); International Patent Application No. PCT/AU99/00391 (WO 00/71063 to Cochlear Limited); and U.S. Pat. No. 7,240,416 to Cochlear Limited.
Medical implants are used in many areas of medicine to enhance the length and/or quality of the life of the implant recipient. Such implants include pacemakers, controlled drug delivery implants and cochlear implants.
A cochlear implant allows for electrical stimulating signals to be applied directly to the auditory nerve fibers of the patient, allowing the brain to perceive a hearing sensation approximating the natural hearing sensation. These stimulating signals are applied by an electrode array implanted into the patient's cochlea.
The electrode array is connected to a stimulator unit which generates the electrical signals for delivery to the electrode array. The stimulator unit in turn is operationally connected to a signal processing unit which also contains a microphone for receiving audio signals from the environment, and for processing these signals to generate control signals for the stimulator.
The signal processing unit is in practice, located externally to the patient and the stimulator is implanted within the patient, usually near the mastoid on the patient's skull and underneath the surrounding tissue. The processor and stimulator may communicate by various wireless means including by a radio frequency link.
During insertion of the electrode, damage to the delicate structures of the patient's cochlea often occurs. This damage may cause a loss of any residual hearing.
Several methods have been proposed to reduce insertion trauma, including pre-curved electrode arrays and the use of insertion tools. However, these have not been particularly successful.
According to one aspect of the present invention, there is provided a device for implanting into the body of a patient, the device comprising: a stimulator for converting an input signal to an electrical signal; at least one wire of an electrode electrically connected to the stimulator for receiving the electrical signal; and; an electrode contact of the electrode electrically connected to the at least one wire for operationally contacting a part of the body of the patient to deliver the electrical signal; wherein at least a portion of one of the at least one wire and/or the electrode contact is made from Carbon Nanotubes (CNTs).
According to a second aspect of the present invention, there is provided a method of manufacturing an electrode array for a medical implant, the method comprising: connecting a wire made at least partially from Carbon Nanotubes (CNTs) forming the conducting wire to an element made at least partially from Carbon Nanotubes (CNTs) forming the electrode contact.
According to a third aspect of the present invention, there is provided an electrode for a medical implant, the electrode comprising a conducting wire and an electrode contact, wherein at least a portion of one of the conducting wire and/or the electrode contact is made from Carbon Nanotubes (CNTs).
Illustrative embodiments of the present invention are described herein with reference to the accompanying figures, in which:
The following describes a number of new techniques for manufacturing an electrode array using carbon nanotubes (CNTs), as well as an implantable medical lead for a cochlear implant comprising an electrode array that is manufactured according to the various techniques as described herein.
An electrode array will be understood to include one or more electrodes. Each electrode will be understood to include an electrode contact and an elongate element, such as a conductive filament or wire or strand of conductive filaments or wires (collectively referred to herein as wire) that is electrically connected to the electrode contact.
According to an embodiment, the electrodes are formed from at least one or more CNTs.
Certain embodiments of this invention will preferably have the following characteristics:
CNT spun wires and sheets are described, for example in the following documents, previously incorporated by reference: “Multifunctional Carbon Nanotube Yarns by Downsizing an Ancient Technology”, Science Vol. 306. no. 5700, pp. 1358-1361 and “Strong, Transparent, Multifunctional, Carbon Nanotube Sheets”, Science Vol. 309. no. 5738, pp. 1215-1219).
The CNT wires or sheets may be formed from SWCNT (Single Wall CNTs) or MWCNT (multiple wall CNTs).
CNT wires and/or sheets can be obtained from government research bodies such as the CSIRO (Commonwealth Scientific and Industrial Research Organisation) in Australia or from commercial companies including: Carbolex, Inc. in Ky., Lexington, USA; Carbon Nanotechnologies Incorporated in Houston Tex., USA; Thomas Swan & Co. Ltd in the United Kingdom; and Sun Nanotech Co Ltd in Nanchang, Jiangxi P.R. China.
Upon obtaining a supply of suitable CNT wire 1 (see
The insulating layer 11 is then removed from the ends of the wire 10, as shown in
Next, upon obtaining a supply of CNT sheets 200, a number of discrete pieces are pressed or otherwise cut from the sheet to provide the CNT electrode contacts 20, 20′, and 20″, as shown in
Forming the electrode array from CNT wires and/or sheets allows the size of each electrode and the thickness of the electrode array to be reduced in comparison with prior art manufacturing methods. Reducing the physical dimensions of each electrode allows the electrode array to be more flexible than those known previously in the art, without comprising on the strength required to withstand the stresses placed upon the electrode array during manufacture, transport, and handling of its lead. Furthermore, increasing the flexibility of the electrode array reduces the restoring force required to return a peri-modiolar designed cochlear implant lead to its original curved shape after being straightened prior to insertion of the lead into the cochlea, such that the thickness of the lead can be further reduced.
In accordance with embodiments of the present invention, the risk of insertion trauma and damage to residual hearing can be substantially reduced.
Each of the electrode contacts 20, 20′, 20″ is then placed in a holding jig, so that they may each be connected to a corresponding wire.
Referring to
Alternatively, the elongate element and contact of the electrode is stamped or otherwise cut as a whole from the sheet of CNT material 200, such that no joining is required, as shown in
In order to form the electrode array, the electrode contact 20, 20′, 20″ are placed in a U-shaped holding die 40, as shown in
As shown in
It will be understood that electrode array arrangements need not use a stylet/lumen arrangement, and the various aspects of the invention are equally applicable to non-lumen/stylet arrangements.
For example, the U-shaped holding die 40 can be flooded with silicone such that the electrode contacts 20, 20′, 20″ are supported in spaced relationship to each other by a partially-constructed lead body 30, as shown in
The electrode array is then removed from the U-shaped holding die 40 and placed in a curved moulding die 60, as shown in
Dimensions of the intra-cochlear electrode array typically chosen for a cochlear implant electrode are 18 mm long. The length of the electrode array can range from 2 mm (for a short/basilar electrode) to 40 mm (a full length electrode). Other dimensions and shapes are also possible as would be understood by the person skilled in the art.
The electrode array described above forms the distal end of a lead/array assembly 30 that is adapted to be connected to an implantable cochlear stimulator (ICS) 31, as shown in
The CNTs can be connected to a standard feedthrough pin (platinum pins held in a ceramic layer) via crimping. More specifically, a notch can be cut into the platinum pin, the CNT conducting strand or wire placed in the notch and the pin then crimped around the CNT conducting strand or wire.
Other methods include tying and knotting the CNT conducting strand or wire onto the feedthrough pin, and then bending the pin down and over the tied CNT conducting strand or wire to lock the CNT conducting strand or wire to the pin, or using conductive adhesive polymers.
Yet another method is to arrange the CNT conducting strand or wires to match the feedthrough pins, embed them in an insulating epoxy (to provide mechanical support), cure the epoxy, polish a bottom side of the embedded strand or wires to expose the aligned CNT conducting strand or wires, and use conductive epoxy to attach the CNT conducting strand or wires to the feedthrough pins.
Moreover, there can be various sizes of electrode contacts. The limitations are based on physically fitting them into the body of the lead. Length of any one contact is dependant on the number of contacts (for example 1-256 contacts). The fewer the number of electrode contacts the larger the length can be, conversely, the higher the number the shorter the length. Width is dependant on the width of the electrode design and whether the electrode contact is flat, or wraps around the surface. In one example, 22 CNT electrode contacts are used. According to one aspect of the present invention however, far more electrodes (and corresponding electrode contacts and conducting strand or wires) may be used, including anywhere from 1 electrode to 256 or more electrodes, and more specifically, including 22 to 50 electrodes, 45 to 70 electrodes, 65 to 90 electrodes, 85 to 120 electrodes, 110 to 150 electrodes, 145 to 190 electrodes, 180 to 220 electrodes, 210 to 240 electrodes, 235 to 256 electrodes. It will also be understood that this includes electrode numbers greater than 256, including 257 to 300, 300 to 350, 350 to 400, 400 to 500, 500 to 600, 600 to 800, 800 to 1000 and above.
It will be appreciated that due to the very high surface area of contacts made out of CNT, the required size for effective electrical stimulation is reduced from that of contacts made from Platinum.
It will also be understood that various combinations of existing materials and structures may be used. For example, one alternative is to join the CNT conducting strand or wires to a traditional electrode contact, such as Platinum (Pt) or Platinum/Iridium (Pt/Ir). hi this case, the joining method may be as described above with reference to
In another alternative combination, ‘traditional’ wires (e.g. Pt or Pt/Ir) used as the conducting strand or wires may be joined to CNT electrode contacts. Again, the method of joining may be as described above.
In an alternative method of constructing an electrode array/lead assembly, a fine mesh, with square openings in the 5 to 10 micrometer range (for example) of biocompatible material, such as room temperature vulcanized (RTV) silicone, is glued on the outer surface of the electrode contacts. This is to hinder fibrous tissue growth on the outer surface of the electrode contact and/or to selectively stimulate only the growth of neuron cells on the outer surface of the electrode contacts.
Alternatively, the outer surface of the electrode contacts may be covered in a thin layer of silicone, and an ablation process used to create openings in the thin layer of silicone to expose the outer surface of the electrode contact. Suitable ablation processes include UV laser (193 run to 248 nm wavelength), ion beam etching, and mechanical and/or chemical polishing.
Alternatively, the outer surface of the electrode contacts may be finished (e.g. ground or pressed) or patterned (e.g. orientated corrugations) to achieve selective biological cell response.
In yet a further alternative, CNTs are deposited in channels formed in a suitable substrate matrix (e.g. silicone (PDMS) RTV matrix); the CNTs are mixed with a curable solution (e.g. PVA, Poly Vinyl Alcohol, a bio-compatible, water based glue) and poured into the channels in the matrix. An electrical field is applied to each channel to align the CNTs in electrical contact with each other, after which the solution is cured. CNT conductive structures are thus created in the substrate matrix. The matrix is sealed using an insulating barrier (e.g. parylene coating or RTV adhesive). Openings are created in the back of the substrate matrix to expose the CNT electrode contact area (for example, using an ablation process as described above), and a fine mesh (micrometer sized openings) of biocompatible material (such as RTV silicone) is deposited on top of the vertically grown CNT electrode contacts to hinder tissue growth on the contact surface and/or to selectively stimulate only the growth of neuron cells on the contact surface. A normal electrode array manufacturing process follows, as will be understood to the person skilled in the art.
In yet a further method of manufacture, the electrode contacts are made out of polyimide foil instead of CNT. After removing the electrode structure from the silicone injection die, the polyimide foil contacts are selectively removed (for example, using an ablation process as described above), thus exposing the non-insulated terminations of the CNT strand or wires in the array.
The array is placed and carefully positioned in a matching die that allows external access only in the area of the array formerly occupied by the polyimide contacts, and ensures surface protection of the rest of the array.
In the openings available on the back of the masking die above, CNT structures are vertically grown through a commercially available growth process such as PECVD (Plasma Enhanced Chemical Vapor Deposition). The CNT structures thus created are in intimate contact (low ohmic resistance) with the conductive CNT strand or wires in the electrode array; a suitable polymer, such as polyvinyl alcohol is deposited in the same openings and cured.
The masking die is removed and surface polishing is used to back trim/level the vertically grown CNT electrode contacts formed, back to the silicone surface of the electrode array. The thus formed CNT contacts may then be left unchanged or further covered with a conductive polymer (such as previously described). The array is placed back in the masking die and a fine mesh (5 to 10 micrometer size openings) of biocompatible material (such as RTV silicone, etc) is glued on top of the vertically grown CNT electrode contacts to hinder fibrous tissue growth on contact surface and/or selectively stimulate only the growth of neuron cells on the CNT electrode contact surface. A conventional electrode array manufacturing process follows.
In yet a further alternative arrangement, both the CNT conducting strand or wire 1 and the CNT electrode contact 20 are stamped from the CNT sheet 200 in a single operation. The CNT conducting strand or wires are coated with a 1 to 6 μm (for example) thick insulating barrier (e.g. Parylene-C) along then-length.
An example of a similar general technique is described in WO 02/089907, in the name of the Applicant of the present application, the entire contents of which are incorporated herein by reference.
The resulting CNT conducting wire and CNT electrode contact structures are arranged in a moulding die in a pattern suitable for a functional electrode array. A biocompatible adhesive (e.g. silicone adhesive) is deposited on the backside of each CNT conducting strand or wire/CNT electrode contact and along (or at points along) the CNT wires' structure to ensure mechanical stability for subsequent manipulation.
While the various aspects of the present invention have been described with specific reference to a cochlear implant and having dimensions suitable for insertion into the cochlea, it will be understood that the principles of the invention may be applied to other types of implantable leads for applications other than cochlear stimulation. For example:
ABI (Auditory Brainstem Implant, electrode for hearing, placed in the brainstem) such as Cochlear Corporation's Nucleus 24 [R] Multichannel Auditory Brainstem Implant (Multichannel ABI).
The auditory brainstem implant consists of a small electrode that is applied to the brainstem where it stimulates acoustic nerves by means of electrical signals. The stimulating electrical signals are provided by a signal processor processing input sounds from a microphone located externally to the patient. This allows the patient to hear a certain degree of sound. Examples of such implants are shown in
FES (Functional Electrical Stimulation)
FES is a technique that uses electrical currents to activate muscles and/or nerves, restoring function in people with paralysis-related disabilities.
Injuries to the spinal cord interfere with electrical signals between the brain and the muscles, which can result in paralysis.
It will be noted for clarity of illustration, the FES system shown in
SCS (Spinal Cord Stimulator)
This system delivers pulses of electrical energy via an electrode in the spinal area and may be used for pain management. An example of a commercially available system is the RESTOREPRIME system by Medtronic, Inc, USA.
In another embodiment, a cochlear implant may be provided that is the same size as (or smaller or larger than) prior art implants, but that has a larger number of electrodes than prior art implants, thereby increasing the fineness of resolution of the coded frequencies and thus increasing effectiveness of the implant.
It will be understood that the above has been described with reference to a particular embodiment and that many variations and modifications may be made to the invention without departing from the scopes of the various aspects of the present invention.
It will also be understood that throughout this specification, unless the context requires otherwise, the words ‘comprise’ and ‘include’ and variations such as ‘comprising’ and ‘including’ will be understood to imply the inclusion of a stated integer or group of integers but not the exclusion of any other integer or group of integers.
The reference to any prior art in this specification is not, and should not be taken as, an acknowledgement or any form of suggestion that such prior art forms part of the common general knowledge.
Number | Date | Country | Kind |
---|---|---|---|
2007906334 | Nov 2007 | AU | national |
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/AU2008/001718 | 11/19/2008 | WO | 00 | 10/29/2010 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2009/065171 | 5/28/2009 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
5833715 | Vachon et al. | Nov 1998 | A |
6548313 | Ravi et al. | Apr 2003 | B1 |
6730972 | Ravi et al. | May 2004 | B2 |
7162308 | O'Brien et al. | Jan 2007 | B2 |
7221982 | Aron et al. | May 2007 | B2 |
7240416 | Milojevic et al. | Jul 2007 | B2 |
7596415 | Brabec et al. | Sep 2009 | B2 |
7630771 | Cauller | Dec 2009 | B2 |
20040038251 | Smalley et al. | Feb 2004 | A1 |
20040065559 | Iijima et al. | Apr 2004 | A1 |
20040111141 | Brabec et al. | Jun 2004 | A1 |
20050075708 | O'Brien et al. | Apr 2005 | A1 |
20050203604 | Brabec et al. | Sep 2005 | A1 |
20060115409 | Li et al. | Jun 2006 | A1 |
20060129215 | Helmus et al. | Jun 2006 | A1 |
20070005117 | Fritsch et al. | Jan 2007 | A1 |
20070209093 | Tohji et al. | Sep 2007 | A1 |
20070225776 | Fritsch et al. | Sep 2007 | A1 |
20070255002 | Alba | Nov 2007 | A1 |
20080170982 | Zhang et al. | Jul 2008 | A1 |
20080203380 | Wang et al. | Aug 2008 | A1 |
Number | Date | Country |
---|---|---|
01375429 | Jan 2004 | EP |
01424095 | Jun 2004 | EP |
0071063 | Nov 2000 | WO |
0076912 | Dec 2000 | WO |
02089907 | Nov 2002 | WO |
03084869 | Oct 2003 | WO |
2004052447 | Jun 2004 | WO |
2005120823 | Dec 2005 | WO |
2006105478 | Oct 2006 | WO |
2007015710 | Feb 2007 | WO |
2007078082 | Jul 2007 | WO |
2007087687 | Aug 2007 | WO |
2007136404 | Nov 2007 | WO |
2008097333 | Aug 2008 | WO |
2008119138 | Oct 2008 | WO |
Entry |
---|
Zhang et al., “Strong, Transparent, Multifunctional, Carbon, Nanotube Sheets”, Science, vol. 309, pp. 1215-1219, Aug. 19, 2005. |
Zhang et al., “Multifunctional Carbon Nanotube Yarns by Downsizing an Ancient Technology” Science, vol. 306, pp. 1358-1361, Nov. 19, 2004. |
Written Opinion of the International Searching Authority, International Application No. PCT/AU2008/001718, mailed Jan. 12, 2009. |
International Searching Report, International Application No. PCT/AU2008/001718, mailed Jan. 12, 2009. |
Meyyappan et al., “Carbon Nanotube Growth by PECVD: A Review”, Plasma Sources Sci. Technol. 12 (2003) 205-216, Apr. 2, 2003 (12 pages). |
Number | Date | Country | |
---|---|---|---|
20110034969 A1 | Feb 2011 | US |